Correlation Between Tarsus Pharmaceuticals and Eterna Therapeutics
Can any of the company-specific risk be diversified away by investing in both Tarsus Pharmaceuticals and Eterna Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Tarsus Pharmaceuticals and Eterna Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Tarsus Pharmaceuticals and Eterna Therapeutics, you can compare the effects of market volatilities on Tarsus Pharmaceuticals and Eterna Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Tarsus Pharmaceuticals with a short position of Eterna Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Tarsus Pharmaceuticals and Eterna Therapeutics.
Diversification Opportunities for Tarsus Pharmaceuticals and Eterna Therapeutics
-0.78 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Tarsus and Eterna is -0.78. Overlapping area represents the amount of risk that can be diversified away by holding Tarsus Pharmaceuticals and Eterna Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Eterna Therapeutics and Tarsus Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Tarsus Pharmaceuticals are associated (or correlated) with Eterna Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Eterna Therapeutics has no effect on the direction of Tarsus Pharmaceuticals i.e., Tarsus Pharmaceuticals and Eterna Therapeutics go up and down completely randomly.
Pair Corralation between Tarsus Pharmaceuticals and Eterna Therapeutics
Given the investment horizon of 90 days Tarsus Pharmaceuticals is expected to generate 0.66 times more return on investment than Eterna Therapeutics. However, Tarsus Pharmaceuticals is 1.51 times less risky than Eterna Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Eterna Therapeutics is currently generating about -0.12 per unit of risk. If you would invest 2,016 in Tarsus Pharmaceuticals on September 19, 2024 and sell it today you would earn a total of 3,310 from holding Tarsus Pharmaceuticals or generate 164.19% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Tarsus Pharmaceuticals vs. Eterna Therapeutics
Performance |
| Timeline |
| Tarsus Pharmaceuticals |
| Eterna Therapeutics |
Tarsus Pharmaceuticals and Eterna Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Tarsus Pharmaceuticals and Eterna Therapeutics
The main advantage of trading using opposite Tarsus Pharmaceuticals and Eterna Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Tarsus Pharmaceuticals position performs unexpectedly, Eterna Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Eterna Therapeutics will offset losses from the drop in Eterna Therapeutics' long position.| Tarsus Pharmaceuticals vs. Emergent Biosolutions | Tarsus Pharmaceuticals vs. Neurocrine Biosciences | Tarsus Pharmaceuticals vs. Teva Pharma Industries | Tarsus Pharmaceuticals vs. Haleon plc |
| Eterna Therapeutics vs. Arcus Biosciences | Eterna Therapeutics vs. Cullinan Oncology LLC | Eterna Therapeutics vs. Annexon | Eterna Therapeutics vs. Structure Therapeutics American |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Other Complementary Tools
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| CEOs Directory Screen CEOs from public companies around the world | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |